Mesoblast (MESO) Cash & Equivalents: 2015-2025
Historic Cash & Equivalents for Mesoblast (MESO) over the last 9 years, with Jun 2025 value amounting to $161.6 million.
- Mesoblast's Cash & Equivalents rose 156.67% to $161.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $161.6 million, marking a year-over-year increase of 156.67%. This contributed to the annual value of $161.6 million for FY2025, which is 156.67% up from last year.
- Per Mesoblast's latest filing, its Cash & Equivalents stood at $161.6 million for Q2 2025, which was up 156.67% from $63.0 million recorded in Q4 2024.
- Over the past 5 years, Mesoblast's Cash & Equivalents peaked at $161.6 million during Q2 2025, and registered a low of $60.4 million during Q2 2022.
- In the last 3 years, Mesoblast's Cash & Equivalents had a median value of $67.1 million in 2023 and averaged $81.8 million.
- Per our database at Business Quant, Mesoblast's Cash & Equivalents crashed by 55.84% in 2022 and then surged by 156.67% in 2025.
- Mesoblast's Cash & Equivalents (Quarterly) stood at $136.9 million in 2021, then tumbled by 55.84% to $60.4 million in 2022, then grew by 17.98% to $71.3 million in 2023, then dropped by 11.72% to $63.0 million in 2024, then skyrocketed by 156.67% to $161.6 million in 2025.
- Its last three reported values are $161.6 million in Q2 2025, $63.0 million for Q4 2024, and $63.0 million during Q2 2024.